These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 27601590)

  • 1. Genome-Wide miRNA Analysis Identifies miR-188-3p as a Novel Prognostic Marker and Molecular Factor Involved in Colorectal Carcinogenesis.
    Pichler M; Stiegelbauer V; Vychytilova-Faltejskova P; Ivan C; Ling H; Winter E; Zhang X; Goblirsch M; Wulf-Goldenberg A; Ohtsuka M; Haybaeck J; Svoboda M; Okugawa Y; Gerger A; Hoefler G; Goel A; Slaby O; Calin GA
    Clin Cancer Res; 2017 Mar; 23(5):1323-1333. PubMed ID: 27601590
    [No Abstract]   [Full Text] [Related]  

  • 2. Genome-wide Discovery and Identification of a Novel miRNA Signature for Recurrence Prediction in Stage II and III Colorectal Cancer.
    Kandimalla R; Gao F; Matsuyama T; Ishikawa T; Uetake H; Takahashi N; Yamada Y; Becerra C; Kopetz S; Wang X; Goel A
    Clin Cancer Res; 2018 Aug; 24(16):3867-3877. PubMed ID: 29514841
    [No Abstract]   [Full Text] [Related]  

  • 3. Deep Sequencing the MicroRNA Transcriptome in Colorectal Cancer.
    Schee K; Lorenz S; Worren MM; Günther CC; Holden M; Hovig E; Fodstad O; Meza-Zepeda LA; Flatmark K
    PLoS One; 2013; 8(6):e66165. PubMed ID: 23824282
    [TBL] [Abstract][Full Text] [Related]  

  • 4. miR-193a-3p is a Key Tumor Suppressor in Ulcerative Colitis-Associated Colon Cancer and Promotes Carcinogenesis through Upregulation of IL17RD.
    Pekow J; Meckel K; Dougherty U; Huang Y; Chen X; Almoghrabi A; Mustafi R; Ayaloglu-Butun F; Deng Z; Haider HI; Hart J; Rubin DT; Kwon JH; Bissonnette M
    Clin Cancer Res; 2017 Sep; 23(17):5281-5291. PubMed ID: 28600480
    [No Abstract]   [Full Text] [Related]  

  • 5. Global and targeted circulating microRNA profiling of colorectal adenoma and colorectal cancer.
    Zhang J; Raju GS; Chang DW; Lin SH; Chen Z; Wu X
    Cancer; 2018 Feb; 124(4):785-796. PubMed ID: 29112225
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Integrated analysis identifies microRNA-195 as a suppressor of Hippo-YAP pathway in colorectal cancer.
    Sun M; Song H; Wang S; Zhang C; Zheng L; Chen F; Shi D; Chen Y; Yang C; Xiang Z; Liu Q; Wei C; Xiong B
    J Hematol Oncol; 2017 Mar; 10(1):79. PubMed ID: 28356122
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A large-scale microRNA transcriptome-wide association study identifies two susceptibility microRNAs, miR-1307-5p and miR-192-3p, for colorectal cancer risk.
    Chen Z; Lin W; Cai Q; Kweon SS; Shu XO; Tanikawa C; Jia WH; Wang Y; Su X; Yuan Y; Wen W; Kim J; Shin A; Jee SH; Matsuo K; Kim DH; Wang N; Ping J; Shin MH; Ren Z; Oh JH; Oze I; Ahn YO; Jung KJ; Gao YT; Pan ZZ; Kamatani Y; Han W; Long J; Matsuda K; Zheng W; Guo X
    Hum Mol Genet; 2024 Feb; 33(4):333-341. PubMed ID: 37903058
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Next generation sequencing profiling identifies miR-574-3p and miR-660-5p as potential novel prognostic markers for breast cancer.
    Krishnan P; Ghosh S; Wang B; Li D; Narasimhan A; Berendt R; Graham K; Mackey JR; Kovalchuk O; Damaraju S
    BMC Genomics; 2015 Sep; 16():735. PubMed ID: 26416693
    [TBL] [Abstract][Full Text] [Related]  

  • 9. miR-196b-5p Regulates Colorectal Cancer Cell Migration and Metastases through Interaction with HOXB7 and GALNT5.
    Stiegelbauer V; Vychytilova-Faltejskova P; Karbiener M; Pehserl AM; Reicher A; Resel M; Heitzer E; Ivan C; Bullock M; Ling H; Deutsch A; Wulf-Goldenberg A; Adiprasito JB; Stoeger H; Haybaeck J; Svoboda M; Stotz M; Hoefler G; Slaby O; Calin GA; Gerger A; Pichler M
    Clin Cancer Res; 2017 Sep; 23(17):5255-5266. PubMed ID: 28533224
    [No Abstract]   [Full Text] [Related]  

  • 10. A Panel of MicroRNA Signature as a Tool for Predicting Survival of Patients with Urothelial Carcinoma of the Bladder.
    Inamoto T; Uehara H; Akao Y; Ibuki N; Komura K; Takahara K; Takai T; Uchimoto T; Saito K; Tanda N; Yoshikawa Y; Minami K; Hirano H; Nomi H; Kato R; Hayashi T; Azuma H
    Dis Markers; 2018; 2018():5468672. PubMed ID: 30026881
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MiRNA-362-3p induces cell cycle arrest through targeting of E2F1, USF2 and PTPN1 and is associated with recurrence of colorectal cancer.
    Christensen LL; Tobiasen H; Holm A; Schepeler T; Ostenfeld MS; Thorsen K; Rasmussen MH; Birkenkamp-Demtroeder K; Sieber OM; Gibbs P; Lubinski J; Lamy P; ; Laurberg S; Oster B; Hansen KQ; Hagemann-Madsen R; Byskov K; Ørntoft TF; Andersen CL
    Int J Cancer; 2013 Jul; 133(1):67-78. PubMed ID: 23280316
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Global miRNA expression analysis of serous and clear cell ovarian carcinomas identifies differentially expressed miRNAs including miR-200c-3p as a prognostic marker.
    Vilming Elgaaen B; Olstad OK; Haug KB; Brusletto B; Sandvik L; Staff AC; Gautvik KM; Davidson B
    BMC Cancer; 2014 Feb; 14():80. PubMed ID: 24512620
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of miR-18a-5p, miR-144-3p, and miR-663b in colorectal cancer and their association with cholesterol homeostasis.
    Sharma B; Randhawa V; Vaiphei K; Gupta V; Dahiya D; Agnihotri N
    J Steroid Biochem Mol Biol; 2021 Apr; 208():105822. PubMed ID: 33465419
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Different miR-21-3p isoforms and their different features in colorectal cancer.
    Jiao W; Leng X; Zhou Q; Wu Y; Sun L; Tan Y; Ni H; Dong X; Shen T; Liu Y; Li J
    Int J Cancer; 2017 Nov; 141(10):2103-2111. PubMed ID: 28734015
    [TBL] [Abstract][Full Text] [Related]  

  • 15. microRNA-202-3p inhibits cell proliferation by targeting ADP-ribosylation factor-like 5A in human colorectal carcinoma.
    Wang Q; Huang Z; Guo W; Ni S; Xiao X; Wang L; Huang D; Tan C; Xu Q; Zha R; Zhang J; Sheng W; He X; Du X
    Clin Cancer Res; 2014 Mar; 20(5):1146-57. PubMed ID: 24327274
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hsa-miR-31-3p expression is linked to progression-free survival in patients with KRAS wild-type metastatic colorectal cancer treated with anti-EGFR therapy.
    Manceau G; Imbeaud S; Thiébaut R; Liébaert F; Fontaine K; Rousseau F; Génin B; Le Corre D; Didelot A; Vincent M; Bachet JB; Chibaudel B; Bouché O; Landi B; Bibeau F; Leroy K; Penault-Llorca F; Van Laethem JL; Demetter P; Tejpar S; Rossi S; Mosakhani N; Osterlund P; Ristamäki R; Sarhadi V; Knuutila S; Boige V; André T; Laurent-Puig P
    Clin Cancer Res; 2014 Jun; 20(12):3338-47. PubMed ID: 24771647
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elevated expression of miR-24-3p is a potentially adverse prognostic factor in colorectal adenocarcinoma.
    Kerimis D; Kontos CK; Christodoulou S; Papadopoulos IN; Scorilas A
    Clin Biochem; 2017 Apr; 50(6):285-292. PubMed ID: 27939727
    [TBL] [Abstract][Full Text] [Related]  

  • 18. LncRNA NEAT1 promotes the tumorigenesis of colorectal cancer by sponging miR-193a-3p.
    Yu HM; Wang C; Yuan Z; Chen GL; Ye T; Yang BW
    Cell Prolif; 2019 Jan; 52(1):e12526. PubMed ID: 30407674
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Global and Targeted miRNA Expression Profiling in Clear Cell Renal Cell Carcinoma Tissues Potentially Links miR-155-5p and miR-210-3p to both Tumorigenesis and Recurrence.
    Zhang J; Ye Y; Chang DW; Lin SH; Huang M; Tannir NM; Matin S; Karam JA; Wood CG; Chen ZN; Wu X
    Am J Pathol; 2018 Nov; 188(11):2487-2496. PubMed ID: 30201497
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential expression of miRNAs in colorectal cancer: comparison of paired tumor tissue and adjacent normal mucosa using high-throughput sequencing.
    Hamfjord J; Stangeland AM; Hughes T; Skrede ML; Tveit KM; Ikdahl T; Kure EH
    PLoS One; 2012; 7(4):e34150. PubMed ID: 22529906
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.